PrimeX News

Sandisk (SNDK) Price Forecast: AI Rally Faces Key Pullback Test
Wed, 24 Jun 2026 21:04:01 GMT
Gold (XAU/USD) Price Forecast: Breakdown Signals Risk of Deeper Correction
Wed, 24 Jun 2026 20:55:51 GMT
Natural Gas Price Forecast: Breakdown Risk vs Resistance Test
Wed, 24 Jun 2026 20:46:44 GMT
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Retreats Ahead Of Micron’s Earnings
Wed, 24 Jun 2026 19:48:03 GMT
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Dives 4.5% As Tankers Openly Transit The Strait Of Hormuz
Wed, 24 Jun 2026 19:06:30 GMT
Gold (XAUUSD), Silver, Platinum Forecasts – Gold Tests Multi-Month Lows As Sell-Off Continues
Wed, 24 Jun 2026 17:08:31 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

ATYR

aTyr Pharma, Inc. Common Stock

0.56

USD

+0.02

+4.54%

Jun 24, 15:59 UTC -4

Closed

exchange

After-Market

0.58

+0.02

+3.12%

ATYR News & Forecasts

featured

aTyr Pharma, Inc. (ATYR) Discusses FDA Feedback and Next Steps for Efzofitimod in Pulmonary Sarcoidosis After Phase III Results Transcript

featured

aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial

Advertisement

Advertisement

Advertisement